GSK 269962 - CAS 850664-21-0
Catalog number: 850664-21-0
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C29H30N8O5
Molecular Weight:
570.60
COA:
Inquire
Targets:
ROCK
Description:
GSK 269962 is a potent ROCK inhibitor with IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively, which displays greater than 30-fold selectivity for ROCK against a panel of serine/threonine kinases. It may be used in OAB treatment. It has been shown to block the generation of inflammatory cytokines in lipopolysaccharide-stimulated monocytes and to induce vasorelaxation in preconstricted rat aorta (IC50 = 35 nM). It lowers blood pressure in a rat model of hypertension. It induced a reduction in blood pressure of approximately 10, 20, and 50 mm Hg at doses of 1, 3, and 30 mg/kg. It represent a novel class of ROCK inhibitors that have profound effects in the vasculature, which may enable us to further evaluate the potential beneficial effects of ROCK inhibition in animal models of cardiovascular as well as other chronic diseases.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>99 %
Appearance:
Solid powder
Synonyms:
GSK269962A;N-[3-[[2-(4-Aminofurazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[[2-(4-morpholinyl)ethyl]oxy]benzamide;Aminofurazanyl-azabenzimidazole 6n;N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide
Solubility:
10 mM in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
GSK 269962 may be used in OAB treatment. It represent a novel class of ROCK inhibitors.
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Grams-Kilos
Density:
1.45±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
InChIKey:
YOVNFNXUCOWYSG-UHFFFAOYSA-N
InChI:
InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)
Canonical SMILES:
CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related ROCK Products


LX7101
(CAS: 1192189-69-7)

LX7101, a pyrrolopyrimidine derivative, is a LIM domain kinase 2 (LIMK2) inhibitor which could be probably effective in the treatment of glaucoma. It has just f...

GSK180736A
(CAS: 817194-38-0)

GSK180736A is a selective GRK2 inhibitor with an IC50 of 0.77 μM. It is also a weak inhibitor of PKA with an IC50 of 30 μM, but highly potent against ROCK1 (IC5...

CAS 557782-81-7 ZINC00881524

ZINC00881524
(CAS: 557782-81-7)

ZINC00881524 is a specific ROCK inhibitor.

CAS 451462-58-1 (S)-H-1152 dihydrochloride

(S)-H-1152 dihydrochloride
(CAS: 451462-58-1)

(S)-H-1152 dihydrochloride is a Rho-kinase inhibitor and cell permeable inhibitor of ROCK (Ki = 1.6 nM).

Netarsudil Mesylate
(CAS: 1422144-42-0)

Verosudil
(CAS: 1414854-42-4)

Verosudil is a selective Rho-kinase inhibitor originated by Aerie Pharmaceuticals. In Jun 2013, Phase-II for Ocular hypertension in USA was discontinued. In Sep...

CAS 1226056-71-8 Thiazovivin

Thiazovivin
(CAS: 1226056-71-8)

SAR-407899 hydrochloride
(CAS: 923262-96-8)

SAR-407899 hydrochloride is the hydrochloride form of SAR-407899, which is a potent, ATP-competitive ROCK inhibitor. It has good antihypertensive activity.

CAS 911417-87-3 KD025 (SLx-2119)

KD025 (SLx-2119)
(CAS: 911417-87-3)

KD025 is an orally available, and selective ROCK2 inhibitor with IC50 and Ki of 60 nM and 41 nm, respectively. Phase 2.

CAS 607373-46-6 SB 772077B dihydrochloride

SB 772077B dihydrochloride
(CAS: 607373-46-6)

SB 772077B dihydrochloride is a potent Rho-kinase (ROCK) inhibitor (IC50 ~ 5.6 nM at recombinant human ROCK1 and 2) exhibiting potent vasodilator activity. SB 7...

CAS 84468-24-6 C-1

C-1
(CAS: 84468-24-6)

C-1 is a protein kinase inhibitor selecitive for PKG, PKA and PKC (IC50 = 4, 8 and 12 µM, respectively) and is widely used as a ROCK inhibitor.

CAS 871543-07-6 H-1152 Dihydrochloride

H-1152 Dihydrochloride
(CAS: 871543-07-6)

H-1152 Dihydrochloride is a cell-permeable isoquinolinesulfonamide compound that acts as a highly specific, potent, and ATP-competitive inhibitor of G-protein R...

K-115
(CAS: 223645-67-8)

K-115, also called as Ripasudil or Glanatec, a selective ROCK inhibitor (IC50 =31 nM), is a promising emerging antiglaucoma drug, and was thus approved by the J...

CAS 173897-44-4 Y-33075 dihydrochloride

Y-33075 dihydrochloride
(CAS: 173897-44-4)

Y-33075 dihydrochloride is a selective ROCK inhibitor (IC50= 3.6nM) derived from Y-27632, and is more potent than Y-27632.

CAS 129830-38-2 Y-27632 2HCl

Y-27632 2HCl
(CAS: 129830-38-2)

Y-27632 2HCl inhibits ROCK-II while displaying little activity against PKC, cAMP-dependent protein kinase and myosin light-chain kinase (MLCK) with Ki of 26 μM,...

CAS 1273579-40-0 Chroman 1

Chroman 1
(CAS: 1273579-40-0)

Chroman 1, a chroman-based compound, is an effective ROCK II inhibitor which could probably influence the cell motility involved in sorts of disorders.

CAS 934387-35-6 ROCK-IN-1

ROCK-IN-1
(CAS: 934387-35-6)

A potent inhibitor of ROCK2 (IC50= 1.2 nM)

CAS 105628-07-7 Fasudil hydrochloride

Fasudil hydrochloride
(CAS: 105628-07-7)

Fasudil HCl, a 5-isoquinolinesulfonamide derivative, is a highly selective Rho-associated protein kinase inhibitor that might have a rate in romoting the recove...

CAS 146986-50-7 Y27632 2HCL

Y27632 2HCL
(CAS: 146986-50-7)

CAS 105628-72-6 Hydroxyfasudil

Hydroxyfasudil
(CAS: 105628-72-6)

Hydroxyfasudil, formed through the metabolism action of Fasudil, could be useful in improving the symptoms of pulmonary hypertension for playing the role as an ...

Chemical Structure

CAS 850664-21-0 GSK 269962

Quick Inquiry

Verification code

Featured Items